Citadel Advisors
ULBI icon

Citadel Advisors’s Ultralife ULBI Stock Holding History

Citadel Advisors’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$538 – 15201
2025
Q1 		$538 Sell
100
-5,900
-98% -$40.1K ﹤0.01% 14248
2024
Q4 		$44.7K Sell
6,000
-400
-6% -$3.29K ﹤0.01% 12503
2024
Q3 		$57.9K Buy
6,400
+3,600
+129% +$37.1K ﹤0.01% 11748
2024
Q2 		$29.7K Sell
2,800
-1,000
-26% -$10.6K ﹤0.01% 12285
2024
Q1 		$33.5K Buy
3,800
+2,900
+322% +$23.6K ﹤0.01% 12582
2023
Q4 		$6.14K Sell
900
-300
-25% -$2.46K ﹤0.01% 13373
2023
Q3 		$11.7K Buy
+1,200
New +$9.62K ﹤0.01% 12995
2023
Q2 		– Sell
-1,000
Closed -$4.02K – 15273
2023
Q1 		$4.02K Sell
1,000
-400
-29% -$1.61K ﹤0.01% 13994
2022
Q4 		$5.4K Buy
+1,400
New +$6.46K ﹤0.01% 14003

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Citadel Advisors's ULBI Position: Q1 2026 in Review

Citadel Advisors reduced its Ultralife (ULBI) stake by 55% in Q1 2026, selling an estimated $316K and leaving 41,301 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #10713.

Citadel Advisors first reported a position in ULBI in Q1 2014 and has held it in 15 quarters since. The position peaked at $829K in Q3 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Citadel Advisors held 41,301 shares of Ultralife worth $269K as of Q1 2026.
  • Citadel Advisors sold 50,812 Ultralife shares in Q1 2026, an estimated $316K.
  • Ultralife made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10713 holding.
  • Citadel Advisors first reported a position in Ultralife in Q1 2014 and has held it in 15 quarters since.
  • Citadel Advisors's Ultralife position peaked at $829K in Q3 2024.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.